In addition, point mutations in the BRCT domain derived from patients with inherited breast cancer result in loss of transcriptional activity, and BRCA1 can also function as a negative regulator on some gene promoters (Chapman and Verma, 1996; Monteiro et al, 1996). This evidence concerns the gene BRCA1 and breast cancer.